2.47

1.65% 0.04

After Hours: 2.45 -0.02 -0.81%

Generation Bio Co (GBIO)

Overview News Price History Option Chain Financials Why GBIO Down? Discussions Forecast

Generation Bio Co stock is traded at $2.47, with a volume of 123.07K. It is up +1.65% in the last 24 hours and down -6.44% over the past month. Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Previous Close:

$2.43

Open:

$2.39

24h Volume:

123.07K

Relative Volume:

1.09

Market Cap:

$162.18M

Revenue:

Net Income/Loss:

$-126.61M

P/E Ratio:

-1.1875

EPS:

-2.08

Net Cash Flow:

$-60.14M

1W Performance:

-13.03%

1M Performance:

-6.44%

6M Performance:

-39.31%

1Y Performance:

-34.83%

1-Day Range:

$2.32

$2.54

1-Week Range:

$2.30

$2.91

52-Week Range:

$0.86

$4.65

Generation Bio Co Stock (GBIO) Company Profile

Name

Generation Bio Co

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

857-529-5908

Address

301 BINNEY STREET, CAMBRIDGE

Employee

174

Twitter

@generationbio

Next Earnings Date

2024-08-05

Latest SEC Filings

GBIO's Discussions on Twitter

Generation Bio Co Stock (GBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-08-22	Initiated	Canaccord Genuity	Buy
Dec-14-21	Downgrade	William Blair	Outperform → Mkt Perform
Jun-08-21	Initiated	JMP Securities	Mkt Outperform
Feb-24-21	Initiated	William Blair	Outperform
Feb-18-21	Initiated	Needham	Buy
Jul-07-20	Initiated	Cowen	Outperform
Jul-07-20	Initiated	JP Morgan	Overweight
Jul-07-20	Initiated	Jefferies	Buy
Jul-07-20	Initiated	Wedbush	Outperform

View All

Generation Bio Co Stock (GBIO) Latest News

Sep 29, 2024

Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - MarketBeat

Sep 29, 2024

Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - Defense World

Sep 29, 2024

Sep 25, 2024

Bank of New York Mellon Corp Has $527,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Sep 25, 2024

Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News - BioSpace

Sep 25, 2024

Sep 19, 2024

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy - BioSpace

Sep 19, 2024

From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform - Fierce Biotech

Sep 19, 2024

Sep 18, 2024

GrowGeneration Corp [GRWG] Investment Guide: What You Need to Know - Knox Daily

Sep 18, 2024

Gen Digital: Strong Growth, Good Fundamentals, And Decent Price Action Make A Buy - Seeking Alpha

Sep 18, 2024

Sep 17, 2024

Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat

Sep 17, 2024

Sep 16, 2024

Insider Sale Alert: Gen Digital Inc [GEN] – Is it Time to sell? - Knox Daily

Sep 16, 2024

Sep 15, 2024

Cornercap Investment Counsel Inc. Sells 16,746 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World

Sep 15, 2024

Generation Bio Co. (NASDAQ:GBIO) Shares Bought by Acadian Asset Management LLC - Defense World

Sep 15, 2024

Sep 14, 2024

Choreo LLC Takes $776,000 Position in Genmab A/S (NASDAQ:GMAB) - MarketBeat

Sep 14, 2024

Sep 13, 2024

Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Los Angeles Capital Management LLC - Defense World

Sep 13, 2024

Sep 12, 2024

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - ForexTV.com

Sep 12, 2024

Moderna falls on R&D cuts, filing delays, terminated programs - BioWorld Online

Sep 12, 2024

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - Marketscreener.com

Sep 12, 2024

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - StockTitan

Sep 12, 2024

Sep 06, 2024

Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% - MarketBeat

Sep 06, 2024

Sep 02, 2024

Holdings of Generation Bio Co (GBIO) are aligned with the stars - SETE News

Sep 02, 2024

Financial Metrics Check: Generation Bio Co (GBIO)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 02, 2024

The Generation Bio Co (GBIO) had a good session last reading, didn’t it? - US Post News

Sep 02, 2024

Aug 29, 2024

Next Generation Bio-therapeutics Market to Exhibit - openPR

Aug 29, 2024

Aug 22, 2024

Pipeline Co-Creation - Evotec

Aug 22, 2024

Aug 15, 2024

Vanguard Group Inc. Buys 18,205 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World

Aug 15, 2024

Aug 12, 2024

Q3 2024 Earnings Forecast for Generation Bio Co. (NASDAQ:GBIO) Issued By Wedbush - Defense World

Aug 12, 2024

Research Analysts Set Expectations for Generation Bio Co.'s Q3 2024 Earnings (NASDAQ:GBIO) - MarketBeat

Aug 12, 2024

Aug 10, 2024

Generation Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance

Aug 10, 2024

Aug 09, 2024

Generation Bio Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Aug 09, 2024

Aug 08, 2024

Generation Bio (NASDAQ:GBIO) Stock Rating Reaffirmed by Wedbush - MarketBeat

Aug 08, 2024

Aug 07, 2024